npj Vaccines (Oct 2024)

mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination

  • Jacqueline K. Shaia,
  • Priya Shukla,
  • Lee Jampol,
  • Rishi P. Singh

DOI
https://doi.org/10.1038/s41541-024-00983-0
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 2

Abstract

Read online

Abstract Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.